Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
In this association study, the 1019C/G (rs6295) promoter polymorphism of the 5-HT1A receptor G/G genotype was associated with PD without AP in a Japanese population.
|
28096880 |
2017 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to investigate the involvement of 5-HT1A receptors on dorsal periaqueductal gray (dPAG) in the behavioral response related to panic disorder in type-1 DBT animals.
|
28799955 |
2017 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Finally, monoaminergic 'risk' genes (SLC6A4, MAOA, HTR1A) were related to SAD, generalized anxiety disorder and women with panic disorder, anxiety traits and response to psychopharmacological and psychotherapeutic interventions.
|
26575296 |
2016 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
BEFREE |
Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-by-environment interaction for panic disorder.
|
23635830 |
2013 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
RGD |
Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze.
|
21421022 |
2011 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The present study revealed that plasma concentration of PAX, 5-HTTLPR genotype, -1019C/G 5-HT(1A) genotype, PAS score at baseline, and adverse effects may influence the therapeutic response to PAX in patients with PD.
|
21688171 |
2011 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
BEFREE |
We analyzed five genes, derived from pharmacological or translational mouse models, in a new case-control study of PD and SAD in European Americans: (1) the serotonin transporter (SLC6A4), (2) the serotonin receptor 1A, (3) catechol-O-methyltransferase, (4) a regulator of g-protein signaling and (5) the gastrin-releasing peptide receptor.
|
18663369 |
2010 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
BEFREE |
This study reinforces the association between HTR1A and PD.
|
20817074 |
2010 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism.
|
19800133 |
2010 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
BEFREE |
Recent positron emission tomography (PET) studies have reported reduced 5-HT1A receptor binding in patients with panic disorder and social anxiety disorder, but not in posttraumatic stress disorder.
|
19423077 |
2009 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Nine gene-candidates, including 5-HTTLPR, MAO-A VNTR, TPH2 rs1386494, 5-HTR1A -1019C-G, 5-HTR2A 102T-C, CCKR1 246G-A, CCKR2 -215C-A, DRD1 -94G-A and COMT Val158Met, were selected for genotyping based on previous positive findings from genetic association studies in PD.
|
18832011 |
2008 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Alterations in 5-HT1A receptor levels are implicated in mood disorders, and a functional C(-1019)G 5-HT1A promoter polymorphism has been associated with depression, suicide, and panic disorder.
|
16467535 |
2006 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder.
|
16316476 |
2006 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
LHGDN |
Regional brain activation on visual presentation of emotional facial stimuli was investigated in 20 patients with panic disorder by means of fMRI at 3 T. All patients were genotyped for the functional -1019C/G 5-HT1A and 5-HTTLPR polymorphisms.
|
16316476 |
2006 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The association with major depression, suicide, and panic disorder of a new functional 5-HT1A polymorphism at C(-1019)G that selectively blocks repression of the 5-HT1A autoreceptor by NUDR further suggests a causative role for altered regulation of this receptor in predisposition to mental illness.
|
15534042 |
2004 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, the third study in this series by Huang and associates (2004) reveals an association of allelic variation of 5-HT1A receptor expression in a wide spectrum of psychopathology including schizophrenia, substance abuse, and panic disorder.
|
15683551 |
2004 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
BEFREE |
Reduced 5-HT1A receptor binding has been reported in panic disorder.
|
15260943 |
2004 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
LHGDN |
These results provide for the first time in vivo evidence for the involvement of 5-HT(1A)Rs in the pathophysiology of PD.
|
14736842 |
2004 |
Panic Disorder
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
We investigated a possible association between this 5-HT1A gene promoter polymorphism and panic disorder by genotyping the 1019C>G single nucleotide polymorphism in 134 panic-disorder patients with and without agoraphobia and matched 134 controls.
|
14984628 |
2004 |
Panic Disorder
|
0.300 |
Biomarker
|
disease |
BEFREE |
HTR1A and HTR2C showed no significant association with panic disorder.
|
12759158 |
2003 |